Skip to main content
Future Oncology logoLink to Future Oncology
. 2016 Nov;12(22):2659. doi: 10.2217/fon.16.10c1

Corrigendum

PMCID: PMC5992564  PMID: 27545219

In the Review by Laura Y Wang & Ian Ganly, titled ‘Nodal metastases in thyroid cancer: prognostic implications and management’, which appeared in the April 2016 issue of Future Oncology 12(7), 981–994 (2016), the Financial & competing interests disclosure was incorrectly presented as:

Footnotes

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

The Financial & competing interests disclosure is correctly presented as:

Financial & competing interests disclosure

This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

The authors and editors would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.


Articles from Future Oncology are provided here courtesy of Taylor & Francis

RESOURCES